An investigation on the use of tributyrin nanoemulsions for docetaxel delivery

Journal of Drug Delivery Science and Technology

Volumn 18, Issue 3, 2008, Pages 189-195

  Perron, M E ^a   Plourde, F ^a   Guerard S ^a   Huynh, L ^b   Allen, C ^b   Leroux, J C ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Apoptosis; Butyrate; Chemotherapy; Docetaxel; Nanoemulsions; Tributyrin

Indexed keywords

ANTIMITOTIC AGENT; BUTYRIC ACID; DOCETAXEL; SOLUBILIZER; TRIBUTYRIN;

APOPTOSIS; CELL GROWTH; CHEMOTHERAPY; EMULSION; FLOW CYTOMETRY; GROWTH INHIBITION; IN VITRO STUDY; INTRAVENOUS ADMINISTRATION; MOUSE; NANOEMULSION; NEOPLASM; TOXICITY;

EID: 70349379140     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(08)50035-9     Document Type: Article

References (38)

1. Herbst R. S., Khuri F. R. - Mode of action of docetaxel - a basis for combination with novel anticancer agents. - Cancer Treat Rev, 29, 407-15, 2003. (Pubitemid 37185107)
2. Hennenfent K. L., Govindan R. - Novel formulations of taxanes: a review. Old wine in a new bottle? - Ann Oncol, 17, 735-49, 2006.
3. Ten Tije A. J., Verweij J., Loos W. J., Sparreboom A. - Pharmacological effects of formulation vehicles: implications for cancer chemotherapy. - Clin Pharmacokinet, 42, 665-85, 2003. (Pubitemid 36936530)
4. Katsumata N. - Docetaxel: an alternative taxane in ovarian cancer. - Br J Cancer, 89 Suppl 3, S9-S15, 2003. (Pubitemid 38067998)
5. Musumeci T., Ventura C. A., Giannone I., Ruozi B., Montenegro L, Pignatello R., Puglisi G. - PLA/PLGA nanoparticles for sustained release of docetaxel. - Int J Pharm, 325, 172-9, 2006. (Pubitemid 44573694)
6. Gaucher G., Dufresne M. H., Sant V. R, Kang N., Maysinger D., Leroux J. C. - Block copolymer micelles: preparation, characterization and application in drug delivery. - J Controlled Release, 109, 169-88, 2005. (Pubitemid 41742123)
7. Goldstein D., Gofrit O., Nyska A., Benita S. - Anti-HER2 cationic immunoemulsion as a potential targeted drug delivery system for the treatment of prostate cancer. - Cancer Res, 67, 269-75, 2007. (Pubitemid 46142784)
8. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. - Tumor vascular permeability and the EPR effect in macromoleculartherapeutics: a review. - J Controlled Release, 65, 271-84, 2000. (Pubitemid 30122932)
9. Moghimi S. M., Hunter A. C., Murray J. C. - Long-circulating and target-specific nanoparticles: theory to practice. - Pharmacol Rev, 53, 283-318, 2001. (Pubitemid 32476118)
10. Yoo C. B., Jones P. A. - Epigenetic therapy of cancer: past, present and future. - Nat Rev Drug Discov, 5, 37-50, 2006.
11. Clarke K. O., Feinman R., Harrison L. E. - Tributyrin, an oral butyrate analogue, induces apoptosis through the activation of caspase-3. - Cancer Lett, 171, 57-65, 2001. (Pubitemid 32727356)
12. Planchon P., Pouillart P., Ronco G., Villa P., Pieri F. - Differential elimination of synthetic butyric triglycerides in vivo: a pharmacokinetic study. - J Pharm Sci, 82, 1046-8, 1993. (Pubitemid 23314110)
13. Maier S., Reich E., Martin R., Bachem M., Altug V., Hautmann R. E., Gschwend J. E. - Tributyrin induces differentiation, growth arrest and apoptosis in androgen-sensitive and androgenresistant human prostate cancer cell lines. - Int J Cancer, 88, 245-51, 2000.
14. Kuefer R., Hofer M. D., Altug V., Zorn C., Genze F., Kunzi-Rapp K., Hautmann R. E., Gschwend J. E. - Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer. - Br J Cancer, 90, 535-41, 2004. (Pubitemid 38258278)
15. Giermasz A., Nowis D., Jalili A., Basak G., Marczak M., Makowski M., Czajka A., Mlynarczuk I., Hoser G., StokOsa T., Lewandowski S., Jakobisiak M. - Antitumor activity of tributyrin in murine melanoma model. - Cancer Lett, 164, 143-8, 2001. (Pubitemid 32155501)
16. Miyake H., Hara S., Arakawa S., Kamidono S., Hara I. - Overexpression of Bcl-2 regulates sodium butyrate-and/or docetaxelinduced apoptosis in human bladder cancer cells both in vitro and in vivo. - Int J Cancer, 93, 26-32, 2001. (Pubitemid 32539497)
17. Kan P., Chen Z. B., Lee C. J., Chu I. M. - Development of nonionic surfactant/phospholipid o/w emulsion as a paclitaxel delivery system. - J Controlled Release, 58, 271-8, 1999. (Pubitemid 29142451)
18. Huynh L, Grant J., Leroux J. C, Delmas P., Allen C. - Predicting the solubility of the anti-cancer agent docetaxel in small molecule excipients using computational methods. - Pharm Res, 25, 147-57, 2008.
19. Edelman M. J., Bauer K., Khanwani S., Tait N., Trepel J., Karp J., Nemieboka N., Chung E. J., Van Echo D. - Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug. - Cancer Chemother Pharmacol, 51, 439-44, 2003. (Pubitemid 36649143)
20. Egorin M. J., Yuan Z. M., Sentz D. L., Plaisance K., Eiseman J. L. - Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats. - Cancer Chemother Pharmacol, 43, 445-53, 1999. (Pubitemid 29187582)
21. Conley B. A., Egorin M. J., Tait N., Rosen D. M., Sausville E. A., Dover G., Fram R. J., Van Echo D. A. - Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors. - Clin Cancer Res, 4, 629-34, 1998. (Pubitemid 28193561)
22. Su J., Ho P. C. - Preparation of tributyrin emulsion and characterization of the binding of the emulsion particles to low-density lipoprotein in vitro. - J Pharm Sci, 93, 1755-65, 2004. (Pubitemid 38823703)
23. Su J., He L., Zhang N., Ho P. C. - Evaluation of tributyrin lipid emulsion with affinity to low-density lipoprotein: pharmacokinetics in adult male Wistar rats and cellular activity on Caco-2 and HepG2 cell lines. - J Pharmacol Exp Ther, 316, 62-70, 2006. (Pubitemid 41832581)
24. Chou T. C., Talalay P. - Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. - Adv Enzyme Regul, 22, 27-55, 1984.
25. Strickley R. G. - Solubilizing excipients in oral and injectable formulations. - Pharm Res, 21, 201-30, 2004. (Pubitemid 38221966)
26. Tian J., Stella V. J. - Degradation of paclitaxel and related compounds in aqueous solutions I: Epimerization. - J Pharm Sci, 97, (3), 1224-1235, 2008.
27. Vasu Dev R., Moses Babu J., Vyas K., Sai Ram P., Ramachandra P., Sekhar N. M., Mohan Reddy D. N., Srinivasa Rao N. - Isolation and characterization of impurities in docetaxel. - J Pharm Biomed Anal, 40, 614-22, 2006. (Pubitemid 43227385)
28. Rossi J., Giasson S., Khalid M., Delmas P., Allen C., Leroux J. C. - Long-circulating poly (ethylene glycol)-coated emulsions to target solid tumors. - Eur J Pharm Biopharm, 67, 329-38, 2007. (Pubitemid 47211921)
29. Schroder C., Eckert K., Maurer H. R. - Tributyrin induces growth inhibitory and differentiating effects on HT-29 colon cancer cells in vitro. - Int J Oncol, 13, 1335-40, 1998.
30. Heerdt B. G., Houston M. A., Anthony G. M., Augenlicht L. H. - Initiation of growth arrest and apoptosis of MCF-7 mammary carcinoma cells by tributyrin, a triglyceride analogue of the short-chain fatty acid butyrate, is associated with mitochondrial activity. - Cancer Res, 59, 1584-91, 1999. (Pubitemid 29160130)
31. Yan J., Xu Y. H. - Tributyrin inhibits human gastric cancer SGC-7901 cell growth by inducing apoptosis and DNA synthesis arrest. - World J Gastroenterol, 9, 660-4, 2003. (Pubitemid 36531534)
32. Schroder C. P., Maurer H. R. - Tributyrin-induced differentiation promotes apoptosis of LS 174T colon cancer cells in vitro. - Int J Oncol, 20, 195-200, 2002.
33. Khalid M. N., Simard P., Hoarau D., Dragomir A., Leroux J. C. - Long circulating poly (ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors. - Pharm Res, 23, 752-8, 2006.
34. Garcion E., Lamprecht A., Heurtault B., Paillard A., Aubert-Pouessel A., Denizot B., Menei P., Benoit J. P. - A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. - Mol. Cancer Ther., 5, 1710-22, 2006. (Pubitemid 44323239)
35. Coon J. S., Knudson W., Clodfelter K., Lu B., Weinstein R. S. - Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance. - Cancer Res., 51, 897-902, 1991.
36. Rahmani M., Reese E., Dai Y., Bauer C., Payne S. G., Dent P., Spiegel S., Grant S. - Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. - Cancer Res, 65, 2422-32, 2005. (Pubitemid 40490154)
37. Floryk D., Huberman E. - Differentiation of androgen-independent prostate cancer PC-3 cells is associated with increased nuclear factor-kappaB activity. - Cancer Res, 65, 11588-96, 2005. (Pubitemid 41821718)
38. Bravo Gonzalez R. C., Huwyler J., Boess F., Walter I., Bittner B. - In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam. - Biopharm Drug Dispos, 25, 37-49, 2004. (Pubitemid 38159262)